Nasal resistance observations in decongestant spray trials.
D000403:Airway Resistance; D001548:Benzalkonium Compounds / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D005029:Ethylenediamines / Q000627:therapeutic use; D006801:Humans; D014663:Nasal Decongestants / Q000627:therapeutic use*; D009668:Nose Diseases / Q000188:drug therapy / Q000503:physiopathology*; D010656:Phenylephrine / Q000627:therapeutic use; D011725:Pyridines / Q000627:therapeutic use; D013876:Thiophenes / Q000627:therapeutic use; D013997:Time Factors
D001548:Benzalkonium Compounds; D004338:Drug Combinations; D005029:Ethylenediamines; D014663:Nasal Decongestants; D011725:Pyridines; D013876:Thiophenes; D010656:Phenylephrine